ESPR Earnings Date 2026
Esperion Therapeutics Inc earnings schedule and quarterly results
Next Earnings Date
TBD
Current Stock Price
$3.18
+0.00% today
Earnings Metrics
EPS (TTM)
$-0.54
Revenue Growth
69.1%
Market Cap
$0.8B
Earnings History
| Quarter | EPS | Revenue | Net Income |
|---|---|---|---|
| Q4 2024 | $-0.28 | $0.33B | $-0.05B |
| Q4 2023 | $-2.03 | $0.12B | $-0.21B |
Trading Around ESPR Earnings
Before Earnings
- Review analyst expectations and consensus estimates
- Check options implied volatility for expected move
- Consider historical earnings surprises
- Monitor pre-announcement guidance
After Earnings
- Compare actual results to estimates
- Listen to the earnings call for guidance
- Watch for analyst rating changes
- Monitor institutional buying/selling
Get Full ESPR Analysis
DCF valuation, AI insights, and institutional ownership data
Frequently Asked Questions
When is ESPR next earnings date?
ESPR (Esperion Therapeutics Inc) has not yet announced its next earnings date. Check back for updates on the upcoming earnings schedule.
What is ESPR earnings per share (EPS)?
ESPR's current earnings per share (EPS) is $-0.54.
How often does ESPR report earnings?
Like most publicly traded US companies, ESPR (Esperion Therapeutics Inc) reports earnings quarterly, typically within 4-6 weeks after each fiscal quarter ends. The company holds an earnings call to discuss results with analysts.
What time does ESPR report earnings?
ESPR typically reports earnings either before market open (BMO) or after market close (AMC). The exact time is usually announced a few days before the earnings date. Check the investor relations page for specific timing.
How has ESPR performed in recent earnings?
In the most recent quarter (Q4 2024), ESPR reported EPS of $-0.28 on revenue of $0.33B.
What do analysts expect for ESPR earnings?
Analyst expectations for ESPR earnings can vary. The company has shown positive revenue growth of 69.1%. View the full analyst ratings page for detailed expectations.